Excimer Laser: A Module of the Alopecia Areata Common Protocol

Journal of Investigative Dermatology Symposium Proceedings

Volumn 16, Issue 1, 2013, Pages S77-S79

  McMichael, Amy J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALOPECIA AREATA; ARTICLE; EXCIMER LASER; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); YOUNG ADULT;

ADULT; ALOPECIA AREATA; HUMANS; LASERS, EXCIMER; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; YOUNG ADULT;

MLCS; MLOWN;

EID: 84907227637     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/jidsymp.2013.31     Document Type: Article

References (25)

1. Al-Mutari, N., 308-nm Excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol 26 (2009), 547–550.
2. Al-Mutari, N., 308-nm Laser for the treatment of alopecia areata. Dermatol Surg 33 (2007), 1483–1487.
3. Asawanonda, P., Anderson, R.R., Chang, Y., et al. 308-nm Excimer laser for the treatment of psoriasis: a dose–response study. Arch Dermatol 136 (2000), 619–624.
4. Bónis, B., Kemény, L., Dobozy, A., et al. 308 nm Excimer laser for psoriasis (letter). Lancet, 350, 1997, 1522.
5. Coven, T.R., Burack, L.H., Gilleaudeau, R., et al. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 133 (1997), 1514–1522.
6. Feldman, S.R., Mellen, B.G., Housman, T.N., et al. Efficacy of 308 nm excimer laser for treatment of psoriasis: results of a multicentric study. J Am Acad Dermatol 46 (2002), 900–906.
7. Gilhar, A., Etzioni, A., Paus, R., Alopecia areata. N Engl J Med 366 (2012), 1515–1525.
8. Gilhar, A., Ullmann, Y., Berkutzki, T., et al. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101 (1998), 62–67.
9. Gundogan, C., Greve, B., Raulin, C., Treatment of alopecia areata with the 308 nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser. Lasers Surg Med 34 (2004), 86–90.
10. Happle, R., Hausen, B.M., Wiesner-Menzel, L., Diphencyprone in the treatment of alopecia areata. Acta Dermatol Venereol 63 (1983), 49–52.
11. Madani, S., Shapiro, J., Alopecia areata update. J Am Acad Dermatol 42 (2000), 549–570.
12. Miller, G.T., Hochman, P.S., Meier, W., et al. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med 178 (1993), 211–222.
13. Novak, Z., Bonis, B., Baltas, E., et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B 67 (2002), 32–38.
14. Olsen, E., Hordinsky, M., McDonald-Hall, S., et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 40 (1999), 242–246.
15. Olsen, E.A., Hordinsky, M.K., Price, V.H., et al. Alopecia areata investigational assessments guidelines—Part II. J Am Acad Dermatol 51 (2004), 400–407.
16. Ozawa, M., Ferenczi, K., Kikuchi, T., et al. 312-Nanometer ultraviolet B light (narrow-Band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189 (1999), 711–718.
17. Park, K.K., Liao, W., Murase, J.E., A review of monochromatic excimer light in vitiligo. Br J Dermatol 167 (2012), 468–478.
18. Passeron, T., Ortonne, J.P., Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 24 (2006), 33–42.
19. Raulin, C., Gundogan, C., Greve, B., et al. Excimer laser therapy of alopecia areata—side-by-side evaluation of a representative area. J Dtsch Dermatol Ges 3 (2005), 524–526.
20. Safavi, K., Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol, 128, 1992, 702.
21. Safavi, K.H., Muller, S.A., Suman, V.J., et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70 (1995), 628–633.
22. Shapiro, J., Lui, H., Tron, V., et al. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 36 (1997), 114–117.
23. van der Steen, P.H., Boezeman, J.B., Happle, R., Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology 184 (1992), 198–201.
24. Wingren, A.G., Parra, E., Varga, M., et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 15 (1995), 235–253.
25. Zakaria, W., Passeron, T., Ostovari, N., et al. 308-nm Excimer laser therapy in alopecia areata. J Am Acad Dermatol 1 (2004), 837–838.